Suppr超能文献

脑室内注射可乐定可释放β-内啡肽以诱导大鼠的黏膜保护作用。

Intracerebroventricular injection of clonidine releases beta-endorphin to induce mucosal protection in the rat.

作者信息

Gyires K, Rónai A Z, Müllner K, Fürst S

机构信息

Department of Pharmacology, Semmelweis University of Medicine, Nagyvárad tér 4., Budapest, Hungary.

出版信息

Neuropharmacology. 2000 Apr 3;39(6):961-8. doi: 10.1016/s0028-3908(99)00195-1.

Abstract

The possibility that the endogenous opioid system could be involved in the central nervous system (CNS)-mediated gastroprotective effect of clonidine was investigated. Intracerebroventricularly (i.c.v.) injected clonidine (470 pmol/rat) inhibited the gastric mucosal lesions induced by (orally administered) acidified ethanol in a significant manner in the rat. The gastroprotective effect of the centrally administered clonidine was antagonised by i.c.v. or intracisternally (i.c.) administered presynaptic alpha-2 adrenoceptor antagonist, yohimbine; the non-selective opioid receptor antagonist, naloxone; and the delta opioid receptor antagonist naltrindole. These results suggest that an interaction between central alpha-2 adrenoceptors and endogenous opioid systems is involved in mediating the mucosal protective effect. beta-endorphin antiserum (i.c.) also antagonised the gastroprotection induced by intracerebroventricularly injected clonidine indicating that beta-endorphin release is likely to be a key factor in the gastroprotective effect of clonidine. Furthermore, the i.c.v. or i.c. injection of beta-endorphin produced a potent gastroprotection in the picomolar range. The mucosal protective effect of clonidine was abolished after vagotomy indicating that the central effect may be conveyed to the periphery by vagal efferents. Since atropine (1 mg/kg i.v.) failed to modify, but hexamethonium (10 mg/kg i.v.) antagonised the gastroprotective effect of clonidine, it would appear that in the periphery nicotinic, but not muscarinic, cholinergic receptors are likely to be involved in the mucosal protective effect of clonidine. In conclusion, clonidine (i.c.v.) induces gastroprotective action by releasing an endogenous opioid substance - most likely beta-endorphin - in the rat. The clonidine-induced central gastroprotection requires the integrity of vagal pathway; cholinergic nicotinic - but not muscarinic - receptors might mediate the effect in the periphery.

摘要

研究了内源性阿片系统是否参与可乐定的中枢神经系统(CNS)介导的胃保护作用。脑室内(i.c.v.)注射可乐定(470 pmol/大鼠)可显著抑制大鼠口服酸化乙醇诱导的胃黏膜损伤。脑室内或脑池内(i.c.)注射突触前α-2肾上腺素能受体拮抗剂育亨宾、非选择性阿片受体拮抗剂纳洛酮和δ阿片受体拮抗剂纳曲吲哚,均可拮抗中枢给予可乐定的胃保护作用。这些结果表明,中枢α-2肾上腺素能受体与内源性阿片系统之间的相互作用参与介导黏膜保护作用。β-内啡肽抗血清(i.c.)也可拮抗脑室内注射可乐定诱导的胃保护作用,表明β-内啡肽释放可能是可乐定胃保护作用的关键因素。此外,脑室内或脑池内注射β-内啡肽在皮摩尔范围内可产生强大的胃保护作用。迷走神经切断术后,可乐定的黏膜保护作用消失,表明中枢作用可能通过迷走神经传出纤维传递至外周。由于静脉注射阿托品(1 mg/kg)未能改变可乐定的胃保护作用,但六甲铵(10 mg/kg静脉注射)可拮抗可乐定的胃保护作用,因此在外周,烟碱能而非毒蕈碱能胆碱能受体可能参与可乐定的黏膜保护作用。总之,在大鼠中,脑室内注射可乐定通过释放内源性阿片物质——最可能是β-内啡肽——诱导胃保护作用。可乐定诱导的中枢胃保护作用需要迷走神经通路的完整性;胆碱能烟碱能而非毒蕈碱能受体可能在外周介导该作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验